SEP-479

Advertisement

cGxPJobs Banner

Septerna Initiates SEP-479 Phase 1 Hypoparathyroidism

SOUTH SAN FRANCISCO, Calif., April 13, 2026 Septerna, Inc. has announced the initiation of its Phase 1 clinical trial...

By cGxPwire Editor
April 14, 2026

Read More

Advertisement

cGxPJobs

Directory